Inhibition of ANGPTL8 protects against diabetes-associated cognitive dysfunction by reducing synaptic loss via the PirB signaling pathway
Xiaoyu Meng(National Clinical Research Center for Digestive Diseases), Xuefeng Yu(Dalian University of Technology)
Cited by 15
Related Papers
Comparison of the effects on glycaemic control and β‐cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel‐group trial (the <scp>CONFIDENCE</scp> study)
|Journal of Internal Medicine|2014|59
Insulin upregulates betatrophin expression via PI3K/Akt pathway
|Scientific Reports|2017|43
LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis
|Nature Communications|2023|43